Faculty Opinions recommendation of Positive affect treatment for depression and anxiety: A randomized clinical trial for a core feature of anhedonia.

Impaired Theory of Mind (ToM) ability is a core feature of psychotic disorders that challenges psychosis treatment. We aimed to explore the effect of a Mindfulness-Based Intervention (MBI) on ToM ability in a randomized clinical trial (RCT). A sample of 36 participants diagnosed with psychotic disorder were recruited from a community center and randomly allocated to Integrated Rehabilitation Treatment (IRT) or IRT+MBI. ToM skills were assessed through the Hinting Test and the Reading the Mind in the Eyes Test (RMET). IRT+MBI scored higher in RMET than IRT at posttreatment. MBI is a promising tool for improving ToM ability in psychosis.Keywords: psychotic disorders, theory of mind, mindfulness-based-interventions.

Download Full-text

Effect of telenursing on levels of depression and anxiety in caregivers of patients with stroke: A randomized clinical trial

Iranian Journal of Nursing and Midwifery Research ◽

10.4103/ijnmr.ijnmr_242_16 ◽

2018 ◽

Vol 23 (4) ◽

pp. 248 ◽

Cited By ~ 2

Author(s):

Masoud Fallahi-Khoshknab ◽

Maryam Goudarzian ◽

Asghar Dalvandi ◽

Ahmad Delbari ◽

Akbar Biglarian

Keyword(s):

Clinical Trial ◽

Randomized Clinical Trial ◽

Depression And Anxiety

Download Full-text

Effects of auricular acupressure on depression and anxiety in older adult residents of long-term care institutions: A randomized clinical trial

Geriatric Nursing ◽

10.1016/j.gerinurse.2020.08.003 ◽

2020 ◽

Author(s):

Yen-Ting Tseng ◽

I-Hui Chen ◽

Pi-Hsia Lee ◽

Pi-Chu Lin

Keyword(s):

Clinical Trial ◽

Randomized Clinical Trial ◽

Older Adult ◽

Long Term Care ◽

Depression And Anxiety ◽

Term Care ◽

Auricular Acupressure

Download Full-text

Movie watching during dialysis sessions reduces depression and anxiety and improves quality of life: A randomized clinical trial

Complementary Therapies in Medicine ◽

10.1016/j.ctim.2020.102488 ◽

2020 ◽

Vol 52 ◽

pp. 102488

Author(s):

Edinara Moraes Morais ◽

Paulo Ricardo Moreira ◽

Eliane Roseli Winkelmann

Keyword(s):

Quality Of Life ◽

Clinical Trial ◽

Randomized Clinical Trial ◽

Depression And Anxiety

Download Full-text

A Randomized Clinical Trial of the Effect of Zinc Supplement on Depression and Anxiety in the Elderly

The Open Public Health Journal ◽

10.2174/1874944502114010537 ◽

2021 ◽

Vol 14 (1) ◽

pp. 537-544

Author(s):

Abolfazl Afzali ◽

Zarichehr Vakili ◽

Shahrbanoo Goli ◽

Hossein Bagheri ◽

Seyedmohammad Mirhosseini ◽

...

Keyword(s):

Clinical Trial ◽

Randomized Clinical Trial ◽

Zinc Supplementation ◽

Statistical Tests ◽

Intervention Group ◽

Depression Scale ◽

The Elderly ◽

Control Group ◽

Depression And Anxiety ◽

Zinc Supplements

Background: Anxiety and depression in the elderly are considered important mental disorders. Objective: This study was designed to determine the effect of zinc Supplementation on depression and anxiety in the elderly. Methods: This study was a parallel randomized clinical trial. A total of 150 elderly aged 60 years and older were allocated into intervention and control groups by using the quadruple blocking method. The elderly in the intervention group received a daily dose of 30 mg zinc supplementation pill for 70 days and the elderly in the control group did not receive this supplement. Depression and anxiety in the elderly were measured using the Geriatric Depression Scale and the Beck Anxiety Inventory, respectively. A significance level of 0.05 was considered for all statistical tests. Results: After the intervention, the mean scores of depression and anxiety in the elderly were significantly decreased in the intervention group, as compared with the control group. Moreover, after the intervention, the serum zinc level in the elderly was significantly increased in the intervention group, as compared with the control group (P<0.05). Conclusion: The use of zinc supplements improved depression and anxiety in the elderly. Therefore, it is recommended to use zinc supplements as a new therapeutic strategy for the prevention and treatment of depression and anxiety in the elderly. Registration No: This research was registered in the Iranian clinical trial system with code IRCT2017071635110N1.

Download Full-text

The effect of medicinal syrup made from silkworm cocoon on mixed anxiety-depression disorder: a triple-blind randomized clinical trial

10.32592/ircmj.2021.23.12.1345 ◽

2021 ◽

Keyword(s):

Clinical Trial ◽

Randomized Clinical Trial ◽

Intervention Group ◽

Final Analysis ◽

Anxiety And Depression ◽

Control Group ◽

Depression And Anxiety ◽

Silkworm Cocoon ◽

And Control ◽

Anxiety Depression

Objective: Silkworm cocoon produced by silkworms with the scientific name of Bombyx mori L. is a well-known medicinal agent mainly composed of proteins. This study was designed to assess the efficacy of syrup made from this natural agent on mild to moderate depression. Design: The study was designed as a triple blind randomized clinical trial (RCT). Sixty patients with mixed anxiety–depressive disorder (MADD) were randomized to receive either intervention (silk syrup plus sertraline) or control (placebo syrup + sertraline) for a period of 12 weeks. Depression and anxiety were assessed by using the Beck depression and anxiety inventories at weeks 0, 6 and 12. Results: Fifty-four patients completed the trial in two groups of intervention (n = 30) and control (n = 24) and entered final analysis. According to the results of this study, the mean of anxiety and depression in weeks 6 and week 12 in the intervention group was significantly lower than the control group (p<0.001). Conclusion: Silk syrup can be beneficial for management of anxiety and depression in mild to moderate MADD. Thus, it is suggested as an adjuvant treatment to increase efficacy of conventional drugs in MADD patients.

Download Full-text